ZHEJIANG SHOUXIANGU PHARMACEUTICAL revenue breakdown overview

ZHEJIANG SHOUXIANGU PHARMACEUTICAL revenue for the last year amounted to 692.00 M CNY, the most of which — 220.86 M CNY — came from its highest performing source at the moment, Broken Ganoderma Lucidum Spore Powder, the year earlier bringing 243.94 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought ZHEJIANG SHOUXIANGU PHARMACEUTICAL 691.68 M CNY, and the year before that — 784.35 M CNY.